Dolby Laboratories, Inc. (NYSE:DLB) insider Kevin J. Yeaman sold 68,548 shares of the company’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $59.66, for a total transaction of $4,089,573.68. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Kevin J. Yeaman also recently made the following trade(s):

  • On Thursday, February 8th, Kevin J. Yeaman sold 50,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $61.32, for a total transaction of $3,066,000.00.
  • On Thursday, February 8th, Kevin J. Yeaman sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.33, for a total transaction of $6,233,000.00.
  • On Monday, December 18th, Kevin J. Yeaman sold 11,130 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.47, for a total transaction of $695,291.10.
  • On Tuesday, December 19th, Kevin J. Yeaman sold 17,590 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.45, for a total transaction of $1,098,495.50.

Shares of Dolby Laboratories, Inc. (NYSE:DLB) traded up $0.08 on Tuesday, reaching $62.52. 340,307 shares of the company were exchanged, compared to its average volume of 451,850. The company has a market cap of $6,231.11, a price-to-earnings ratio of 99.24, a PEG ratio of 5.07 and a beta of 0.78. Dolby Laboratories, Inc. has a 12-month low of $48.00 and a 12-month high of $74.29.

Dolby Laboratories (NYSE:DLB) last announced its earnings results on Wednesday, January 24th. The electronics maker reported $0.79 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.44 by $0.35. The firm had revenue of $287.80 million during the quarter, compared to analyst estimates of $265.75 million. Dolby Laboratories had a net margin of 6.06% and a return on equity of 12.02%. Dolby Laboratories’s revenue was up 8.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.66 EPS. equities analysts forecast that Dolby Laboratories, Inc. will post 0.99 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, February 14th. Investors of record on Monday, February 5th will be given a $0.16 dividend. The ex-dividend date of this dividend is Friday, February 2nd. This represents a $0.64 dividend on an annualized basis and a yield of 1.02%. Dolby Laboratories’s dividend payout ratio is presently 101.59%.

Several equities analysts have recently commented on the stock. B. Riley lowered shares of Dolby Laboratories to a “hold” rating and set a $63.00 price target for the company. in a research report on Thursday, January 25th. Zacks Investment Research lowered shares of Dolby Laboratories from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 31st. Finally, JPMorgan Chase & Co. upped their price target on shares of Dolby Laboratories from $63.00 to $70.00 and gave the stock a “neutral” rating in a research report on Thursday, January 25th. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $62.00.

A number of institutional investors and hedge funds have recently made changes to their positions in DLB. Ameriprise Financial Inc. grew its position in Dolby Laboratories by 14.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 17,882 shares of the electronics maker’s stock valued at $862,000 after buying an additional 2,232 shares in the last quarter. Northern Trust Corp grew its position in Dolby Laboratories by 0.3% in the 2nd quarter. Northern Trust Corp now owns 273,724 shares of the electronics maker’s stock valued at $13,401,000 after buying an additional 836 shares in the last quarter. Virtu KCG Holdings LLC bought a new position in Dolby Laboratories in the 2nd quarter valued at about $366,000. Dimensional Fund Advisors LP grew its position in Dolby Laboratories by 0.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 536,657 shares of the electronics maker’s stock valued at $26,276,000 after buying an additional 2,648 shares in the last quarter. Finally, Balyasny Asset Management LLC grew its position in Dolby Laboratories by 400.6% in the 2nd quarter. Balyasny Asset Management LLC now owns 19,433 shares of the electronics maker’s stock valued at $951,000 after buying an additional 15,551 shares in the last quarter. Hedge funds and other institutional investors own 52.74% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This news story was first published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this news story on another website, it was illegally stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://theolympiareport.com/2018/02/13/dolby-laboratories-inc-dlb-insider-sells-4089573-68-in-stock.html.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.